SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001385508-22-000038
Filing Date
2022-03-15
Accepted
2022-03-15 16:08:46
Documents
79
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K opnt-20211231.htm   iXBRL 10-K 1826614
2 EX-4.2 exhibit421.htm EX-4.2 19591
3 EX-23.1 opntconsent231.htm EX-23.1 2789
4 EX-31.1 opnt12312021exhibit311.htm EX-31.1 11478
5 EX-31.2 opnt12312021exhibit312.htm EX-31.2 13337
6 EX-32.1 opnt12312021exhibit321.htm EX-32.1 7744
7 EX-32.2 opnt12312021exhibit322.htm EX-32.2 7382
  Complete submission text file 0001385508-22-000038.txt   7296145

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20211231.xsd EX-101.SCH 47445
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20211231_cal.xml EX-101.CAL 58799
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20211231_def.xml EX-101.DEF 276836
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20211231_lab.xml EX-101.LAB 617137
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20211231_pre.xml EX-101.PRE 449739
73 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20211231_htm.xml XML 948195
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38193 | Film No.: 22741146
SIC: 2834 Pharmaceutical Preparations